Medical Weight Loss for Greenwood, Indiana Residents

Greenwood, Indiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Greenwood through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Two GLP-1 options, shipped to Greenwood: compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and tirzepatide with Mounjaro and Zepbound. These are not FDA-approved and not brand-identical; Dr. Sharma helps Indiana patients choose. Doctor review just $119 (medication separate).

Why Greenwood Residents Choose New Hope Weight Loss

Some patients in Greenwood are weighing semaglutide against tirzepatide, and that is a conversation worth having with a doctor, not a website. Dr. Anjmun Sharma helps you understand the trade-offs, the cost difference between $166 and $233 a month, and what the trial data actually showed, with semaglutide averaging about 15 to 17 percent body-weight loss and tirzepatide reaching up to 22.5 percent at qualifying doses. These are compounded, not brand-identical, and results vary, so the choice should be informed.

Greenwood patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.

You do not need a clinic on your street in Greenwood to work with a real physician, because everything Dr. Sharma offers from Costa Mesa reaches patients across Indiana by secure telehealth. We care for patients throughout downtown Greenwood and the southern Indianapolis metro area of Johnson County. A licensed care coordinator stays reachable by message and phone, so help is a few taps away anywhere in Indiana.

Distance simply stops mattering here, since every appointment for Greenwood residents takes place over secure video rather than in a waiting room. The $119 fee covers the physician review and visit itself; the medication, whether semaglutide from $166 a month or tirzepatide from $233, is a separate charge. New Hope Weight Loss treats patients throughout Indiana entirely by telehealth from our Costa Mesa, California clinic, so the same physician care comes to you wherever you live in the state.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset

This is the program most people ask us about first. For $499 across 90 days, or from $166/mo, you get semaglutide plus monthly physician oversight. Semaglutide uses the same active ingredient as Wegovy and Ozempic, and branded-drug trials averaged 15 to 17 percent body-weight loss. It is compounded, so it is not FDA-approved or brand-identical, and results vary.

Tirzepatide for a dual-pathway approach

From $233/mo, tirzepatide combines GLP-1 and GIP signaling. Branded-drug studies showed up to 22.5 percent loss at qualifying doses, a high-end figure that is not typical. It shares an active ingredient with Mounjaro and Zepbound.

Plan on a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted, and there is no extra charge for Greenwood telehealth visits.

How Telehealth Works for Greenwood

From your first quiz to your last follow-up, the process is built for busy people in Greenwood.

1. Complete a secure online intake about your medical history and weight goals.

2. Dr. Sharma reviews it and meets you over secure video, usually within 48 hours.

3. If a compounded GLP-1 suits you, a state-licensed 503(a) pharmacy ships semaglutide or tirzepatide to your Greenwood home in cold-pack packaging.

4. You continue with video follow-ups, anywhere in , at the cadence your plan calls for.

Frequently Asked Questions, Greenwood

How does someone in Greenwood access New Hope Weight Loss?

Access from Greenwood is entirely online. Our one physical clinic stands in Costa Mesa, California, while we serve Greenwood, Indiana through telehealth. To begin, Dr. Anjmun Sharma meets you over secure video, reviews your background, and confirms whether you are eligible for a compounded GLP-1 program.

Is a clinic visit part of the process for Greenwood residents?

A clinic visit is never part of it for Greenwood. The model is fully telehealth, so your consult, refills, and check-ins happen from home. After Dr. Sharma approves you, medication is shipped to Greenwood inside cold-pack packaging designed to maintain a steady temperature during transit.

What are the fees for Greenwood patients?

The physician review costs $119. Compounded semaglutide runs from $166 each month, or $499 for the 90-day program, and tirzepatide from $233 each month. Medication is billed on its own. We honor HSA, FSA, Klarna, and Affirm, and Greenwood residents are charged no distance surcharge.

What areas of Greenwood do you serve?

We serve patients from across Greenwood by telehealth, including downtown Greenwood and the southern Indianapolis metro area of Johnson County.

How is medication shipped to Greenwood patients?

After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Greenwood address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.

Greenwood Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Greenwood, Indiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.